GL1X · GenesisL1 explorer

MolNFT v1 · #109054 · protein

Crystal structure of rorc in complex with a benzyl sulfonamide inverse agonist

4WQP · Nuclear receptor ror-gamma: “Crystal structure of rorc in complex with a benzyl sulfonamide inverse agonist”. X-ray diffraction, 2 ligands (3SX, SO4), 10 pockets (best druggability 0.82). MolNFT v1 #109054 on GenesisL1: 3D…

PDB
4WQP
Type
protein
Length
468 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma; Val-glu-arg-leu-gln-ile-phe-gln-his-leu-his-pro-ile
UniProt
P51449
Ligands
3SX, SO4
Pockets
10 · best druggability 0.82

Structure

x-ray diffraction · 3 distinct chains · 72% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein23472% helix, 4% strandP51449
BNuclear receptor ror-gammaprotein22172% helix, 5% strandP51449
PVal-glu-arg-leu-gln-ile-phe-gln-his-leu-his-pro-ileprotein1362% helix, 0% strand—

Ligands and binding sites

  • 3SX · N-[4-(4-acetylpiperazin-1-yl)benzyl]-N-(2-methylpropyl)-1-phenylmethanesulfonamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13670.820.91373SX, SO4
23800.820.90393SX, SO4
32930.660.8244empty
41930.570.8022empty
52720.560.7722empty

Interfaces

3 interfaces between chains.

  • B–P · 636 Ų buried · 6 hydrogen bonds · protein-protein
  • A–P · 590 Ų buried · 1 hydrogen bond · protein-protein
  • A–B · 289 Ų buried · 0 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.